Get the app
US › Healthcare

Alterity Therapeutics Ltd (ATHE)

US · Healthcare · Biotechnology

$3.75-2.60%
Last close · 2026-09-17

Key statistics

Market cap
$70.1M
Forward P/E
0.0
P/B
2.11
Book value
$1.68
EPS (TTM)
$-1.04
52-week high
$5.89
52-week low
$2.66
50-day MA
$4.62
200-day MA
$4.02
Beta
-0.04

Analyst view

Analysts rate Alterity Therapeutics Ltd a buy (2 buy, 1 hold, 0 sell out of 3) with an average price target of $13.25.

Shareholding

Institutions
2.15%

Largest institutional holders

FundStake
Twin Lakes Capital Management, LLC0.77%
Greenleaf Trust0.34%
HB Wealth Management, LLC0.32%
Morgan Stanley - Brokerage Accounts0.32%
Citadel Advisors Llc0.11%
BNP Paribas Arbitrage, SA0.04%
GAMMA Investing LLC0.01%
Rhumbline Advisers0.01%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Alterity Therapeutics Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.